Sarissa Capital Management LP

Sarissa Capital Management LP latest Q4_2020 13F filings reported $979,780,000 in market value on this 2021-02-16 report date . The portfolio quarterly return is 15.35%. This fund has 12 securities concentrations of 100% weights.

Sarissa Capital Management LP largest holding is Ironwood Pharmaceuticals Inc. Class A with weight of 16.32% and $159,915,000 in market value. The portfolio return is computed based on the amount invested in the new quarter. The following shows the portfolio details.

Portfolio Performance History

FILE DATEREPORT PERIODQTR YEARFILE TYPENOS. OF STOCKSREPORTED VALUERETURN
2021-02-162020-12-31Q4_202013F-HR12$979,780,00015.35%

Portfolio Details

Stock NameTickersValueCurrent Value (x1000)Change Value %WeightComputed PriceShares Change %Current Shares
IRONWOOD PHARMACEUTICALS INCIRWDINCR$159,91526.63%16.32%$11.39-100.00%14,040,000
ALKERMES PLCALKSINCR$158,60222.32%16.19%$19.95-98.40%7,950,000
BIOGEN INCBIIBDECR$157,444-13.68%16.07%$244.860.00%643,000
JAZZ PHARMACEUTICALS PLC SHS USDJAZZINCR$153,18215.75%15.63%$165.05-100.00%928,100
ALEXION PHARMACEUTICALS INCALXNINCR$124,63836.54%12.72%$156.24-100.00%797,740
INNOVIVA INCINVAINCR$79,46918.56%8.11%$12.39-100.00%6,414,000
MERSANA THERAPEUTICS INCMRSNINCR$77,88747.45%7.95%$26.61-96.83%2,927,000
BIOCRYST PHARMACEUTICALS INCBCRXINCR$60,903264.75%6.22%$7.45-31.82%8,175,000
SARISSA CAPITAL ACQUISITN COSRSAWBUY$4,9990.00%0.51%$1.500.00%3,333,333
REGULUS THERAPEUTICS INCRGLSINCR$2,499162.78%0.26%$1.35-100.00%1,851,851
MIRATI THERAPEUTICS INCMRTXINCR$21931.93%0.02%$219.00-100.00%1,000
INTERCEPT PHARMACEUTICALS INICPTDECR$23-99.95%0.00%$24.21-199.92%950